Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2011, Article ID 134020, 10 pages
http://dx.doi.org/10.1155/2011/134020
Review Article

Conversion of Tumors into Autologous Vaccines by Intratumoral Injection of -Gal Glycolipids that Induce Anti-Gal/ -Gal Epitope Interaction

Department of Surgery, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA

Received 13 July 2011; Accepted 5 September 2011

Academic Editor: Trina J. Stewart

Copyright © 2011 Uri Galili. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hanto, “Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies,” Annual Review of Medicine, vol. 46, pp. 381–394, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. P. T. Straten, J. C. Becker, P. Guldberg, and J. Zeuthen, “In situ T cells in melanoma,” Cancer Immunology Immunotherapy, vol. 48, no. 7, pp. 386–395, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Zhang, J. R. Conejo-Garcia, D. Katsaros et al., “Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer,” New England Journal of Medicine, vol. 348, no. 3, pp. 203–213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Galon, A. Costes, F. Sanchez-Cabo et al., “Type, density, and location of immune cells within human colorectal tumors predict clinical outcome,” Science, vol. 313, no. 5795, pp. 1960–1964, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Galon, W. H. Fridman, and F. Pagès, “The adaptive immunologic microenvironment in colorectal cancer: a novel perspective,” Cancer Research, vol. 67, no. 5, pp. 1883–1886, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Mlecnik, M. Tosolini, A. Kirilovsky et al., “Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction,” Journal of Clinical Oncology, vol. 29, no. 6, pp. 610–618, 2011. View at Publisher · View at Google Scholar
  7. O. J. Finn, “Cancer immunology,” New England Journal of Medicine, vol. 358, no. 25, pp. 2704–2715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Smyth, D. I. Godfrey, and J. A. Trapani, “A fresh look at tumor immunosurveillance and immunotherapy,” Nature Immunology, vol. 2, no. 4, pp. 293–299, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. G. P. Dunn, T. A. Bruce, H. Ikeda, L. J. Old, and R. D. Schreiber, “Cancer immunoediting: from immunosurveillance to tumor escape,” Nature Immunology, vol. 3, no. 11, pp. 991–998, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. H. T. Khong and N. P. Restifo, “Natural selection of tumor variants in the generation of "tumor escape" phenotypes,” Nature Immunology, vol. 3, no. 11, pp. 999–1005, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. L. D. Wood, D. W. Parsons, S. Jones et al., “The genomic landscapes of human breast and colorectal cancers,” Science, vol. 318, no. 5853, pp. 1108–1113, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. B. A. Weir, M. S. Woo, G. Getz et al., “Characterizing the cancer genome in lung adenocarcinoma,” Nature, vol. 450, no. 7171, pp. 893–898, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Mumberg, M. Wick, and H. Schreiber, “Unique tumor antigens redefined as mutant tumor-specific antigens,” Seminars in Immunology, vol. 8, no. 5, pp. 289–293, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Galili, “Autologous tumor vaccines processed to express α-gal epitopes: a practical approach to immunotherapy in cancer,” Cancer Immunology, Immunotherapy, vol. 53, no. 11, pp. 935–945, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Maass, W. Schmidt, M. Berger et al., “Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 12, pp. 5540–5544, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. Zinkernagel, E. Ehl, P. Aichele, T. Kündig, and H. Hengartner, “Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity,” Immunological Reviews, vol. 156, pp. 199–209, 1997. View at Google Scholar · View at Scopus
  17. K. J. Malmberg, “Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?” Cancer Immunology, Immunotherapy, vol. 53, no. 10, pp. 879–891, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Staveley-O'Carroll, E. Sotomayor, J. Montgomery et al., “Induction of antigen-specific T cell anergy: an early event in the course of tumor progression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 3, pp. 1178–1183, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Furumoto, L. Soares, E. G. Engleman, and M. Merad, “Induction of potent antitumor immunity by in situ targeting of intratumoral DCs,” Journal of Clinical Investigation, vol. 113, no. 5, pp. 774–783, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Mastrangelo, H. C. Maguire Jr., L. C. Eisenlohr et al., “Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma,” Cancer Gene Therapy, vol. 6, no. 5, pp. 409–422, 1999. View at Google Scholar · View at Scopus
  21. F. Manca, D. Fenoglio, G. Li Pira, A. Kunkl, and F. Celada, “Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies,” Journal of Experimental Medicine, vol. 17, no. 1, pp. 37–48, 1991. View at Publisher · View at Google Scholar · View at Scopus
  22. E. J. Gosselin, K. Wardwell, D. R. Gosselin, N. Alter, J. L. Fisher, and P. M. Guyre, “Enhanced antigen presentation using human Fcγ receptor (monocyte/macrophage)-specific immunogens,” Journal of Immunology, vol. 149, no. 11, pp. 3477–3481, 1992. View at Google Scholar · View at Scopus
  23. E. Celis, K. G. Abraham, and R. W. Miller, “Modulation of the immunological response to hepatitis B virus by antibodies,” Hepatology, vol. 7, no. 3, pp. 563–568, 1987. View at Google Scholar · View at Scopus
  24. J. V. Ravetch and R. A. Dynes, “Divergent roles for Fc receptors and complement in vivo,” Annual Review of Immunology, vol. 16, pp. 421–432, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Villinger, A. E. Mayne, P. Bostik et al., “Evidence for antibody-mediated enhancement of simian immunodeficiency virus (SIV) Gag antigen processing and cross presentation in SIV-infected rhesus macaques,” Journal of Virology, vol. 77, no. 1, pp. 10–24, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Regnault, D. Lankar, V. Lacabanne et al., “Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class i-restricted antigen presentation after immune complex internalization,” Journal of Experimental Medicine, vol. 189, no. 2, pp. 371–380, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. K. A. Berlyn, B. Schultes, B. Leveugle, A. A. Noujaim, R. B. Alexander, and D. L. Mann, “Generation of CD4+ and CD8+ T lymphocyte responses by dendritic cells armed with PSA/anti-PSA (antigen/antibody) complexes,” Clinical Immunology, vol. 101, no. 3, pp. 276–283, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Rafiq, A. Bergtold, and R. Clynes, “Immune complex-mediated antigen presentation induces tumor immunity,” Journal of Clinical Investigation, vol. 110, no. 1, pp. 71–79, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. K. M. Dhodapkar, J. Krasovsky, B. Williamson, and M. V. Dhodapkar, “Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific killer T cells by dendritic cells,” Journal of Experimental Medicine, vol. 195, no. 1, pp. 125–133, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Groh, Y. Q. Li, D. Cioca et al., “Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonized tumor cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 18, pp. 6461–6466, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. U. Galili, E. A. Rachmilewitz, A. Peleg, and I. Flechner, “A unique natural human IgG antibody with anti-α-galactosyl specificity,” Journal of Experimental Medicine, vol. 160, no. 5, pp. 1519–1531, 1984. View at Google Scholar · View at Scopus
  32. U. Galili, R. E. Mandrell, R. M. Hamadeh, S. B. Shohet, and J. M. Griffiss, “Interaction between human natural anti-α-galactosyl immunoglobulin G and bacteria of the human flora,” Infection and Immunity, vol. 56, no. 7, pp. 1730–1737, 1988. View at Google Scholar · View at Scopus
  33. U. Galili, B. A. Macher, J. S. Buehler, and S. B. Shohet, “Human natural anti-α-galactosyl IgG. II. The specific recognition of α(1→3)-linked galactose residues,” Journal of Experimental Medicine, vol. 162, no. 2, pp. 573–582, 1985. View at Google Scholar · View at Scopus
  34. U. Galili, J. Buehler, S. B. Shohet, and B. A. Macher, “The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies,” Journal of Experimental Medicine, vol. 165, no. 3, pp. 693–704, 1987. View at Google Scholar · View at Scopus
  35. U. Galili, M. R. Clark, S. B. Shohet, J. Buehler, and B. A. Macher, “Evolutionary relationship between the natural anti-Gal antibody and the Galα1→3Gal epitope in primates,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 5, pp. 1369–1373, 1987. View at Google Scholar · View at Scopus
  36. U. Galili, S. B. Shohet, E. Kobrin, C. L. M. Stults, and B. A. Macher, “Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells,” Journal of Biological Chemistry, vol. 263, no. 33, pp. 17755–17762, 1988. View at Google Scholar · View at Scopus
  37. U. Galili, “Evolution and pathophysiology of the human natural anti-α-galactosyl IgG (anti-Gal) antibody,” Springer Seminars in Immunopathology, vol. 15, no. 2-3, pp. 155–171, 1993. View at Google Scholar · View at Scopus
  38. B. A. Macher and U. Galili, “The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: a carbohydrate of unique evolution and clinical relevance,” Biochimica et Biophysica Acta, vol. 1780, no. 2, pp. 75–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. R. D. Larsen, C. A. Rivera-Marrero, L. K. Ernst, R. D. Cummings, and J. B. Lowe, “Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:β-D-Gal(1,4)-D-GlcNAc α(1,3)-galactosyltransferase cDNA,” Journal of Biological Chemistry, vol. 265, no. 12, pp. 7055–7061, 1990. View at Google Scholar · View at Scopus
  40. U. Galili and K. Swanson, “Gene sequences suggest inactivation of α-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 16, pp. 7401–7404, 1991. View at Google Scholar · View at Scopus
  41. D. H. Joziasse, J. H. Shaper, E. W. Jabs, and N. L. Shaper, “Characterization of an α1→3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene,” Journal of Biological Chemistry, vol. 266, no. 11, pp. 6991–6998, 1991. View at Google Scholar · View at Scopus
  42. U. Galili, “Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans,” Immunology Today, vol. 14, no. 10, pp. 480–482, 1993. View at Publisher · View at Google Scholar · View at Scopus
  43. A. H. Good, D. K. Cooper, A. J. Malcolm et al., “Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans,” Transplantation Proceedings, vol. 24, no. 2, pp. 559–562, 1992. View at Google Scholar · View at Scopus
  44. M. Sandrin, H. A. Vaughan, P. L. Dabkowski, and I. F. C. McKenzie, “Anti-pig IgM antibodies in human serum react predominantly with Gal(α1- 3)Gal epitopes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 23, pp. 11391–11395, 1993. View at Publisher · View at Google Scholar · View at Scopus
  45. B. H. Collins, H. A. Cotterell, K. R. McCurry et al., “Cardiac xenografts between primate species provide evidence for the importance of the α-galactosyl determinant in hyperacute rejection,” Journal of Immunology, vol. 154, no. 10, pp. 5500–5510, 1995. View at Google Scholar · View at Scopus
  46. U. M. Abdel-Motal, K. Wigglesworth, and U. Galili, “Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody,” Vaccine, vol. 27, no. 23, pp. 3072–3082, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. A. D. Thall, P. Maly, and J. B. Lowe, “Oocyte Galα1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse,” Journal of Biological Chemistry, vol. 270, no. 37, pp. 21437–21440, 1995. View at Publisher · View at Google Scholar · View at Scopus
  48. U. Galili, K. Wigglesworth, and U. M. Abdel-Motal, “Accelerated healing of skin burns by anti-Gal/α-gal liposomes interaction,” Burns, vol. 36, no. 2, pp. 239–251, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Wigglesworth, W. J. Racki, R. Mishra, E. Szomolanyi-Tsuda, D. L. Greiner, and U. Galili, “Rapid recruitment and activation of macrophages by anti-gal/α-gal liposome interaction accelerates wound healing,” Journal of Immunology, vol. 186, no. 7, pp. 4422–4432, 2011. View at Publisher · View at Google Scholar
  50. U. M. Abdel-Motal, H. M. Guay, K. Wigglesworth, R. M. Welsh, and U. Galili, “Immunogenicity of influenza virus vaccine is increased by anti-gal-mediated targeting to antigen-presenting cells,” Journal of Virology, vol. 81, no. 17, pp. 9131–9141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. U. M. Abdel-Motal, S. Wang, S. Lu, K. Wigglesworth, and U. Galili, “Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galα1-3Galβ1-4GlcNAc-R epitopes,” Journal of Virology, vol. 80, no. 14, pp. 6943–6951, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. D. C. LaTemple, J. T. Abrams, S. U. Zhang, and U. Galili, “Increased immunogenicity of tumor vaccines complexed with anti-gal: studies in knockout mice for α1,3galactosyltransferase,” Cancer Research, vol. 59, no. 14, pp. 3417–3423, 1999. View at Google Scholar · View at Scopus
  53. G. R. Rossi, M. R. Mautino, R. C. Unfer, T. M. Seregina, N. Vahanian, and C. J. Link, “Effective treatment of preexisting melanoma with whole cell vaccines expressing α(1,3)-galactosyl epitopes,” Cancer Research, vol. 65, no. 22, pp. 10555–10561, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. G. R. Rossi, R. C. Unfer, T. Seregina, and C. J. Link, “Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing α(1,3) galactosyl epitopes,” Cancer Immunology, Immunotherapy, vol. 54, no. 10, pp. 999–1009, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Deguchi, M. Tanemura, E. Miyoshi et al., “Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express α-Gal epitopes: a novel approach to immunotherapy in pancreatic cancer,” Cancer Research, vol. 70, no. 13, pp. 5259–5269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. L. Deriy, H. Ogawa, G. Gao, and U. Galili, “In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the α1, 3galactosyltransferase gene,” Cancer Gene Therapy, vol. 12, no. 6, pp. 528–539, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. U. Galili, K. Wigglesworth, and U. M. Abdel-Motal, “Intratumoral injection of α-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines,” Journal of Immunology, vol. 178, no. 7, pp. 4676–4687, 2007. View at Google Scholar · View at Scopus
  58. T. Eto, Y. Ichikawa, K. Nishimura, S. Ando, and T. Yamakawa, “Chemistry of lipid of the posthemolytic residue or stroma of erythrocytes: XVI. occurrence of ceramide pentasaccharide in the membrane of erythocytes and reticulocytes of rabbit,” Journal of Biochemistry, vol. 64, no. 2, pp. 205–213, 1968. View at Google Scholar
  59. K. Stellner, H. Saito, and S. Hakomori, “Determination of aminosugar linkages in glycolipids by methylation. Aminosugar linkages of ceramide pentasaccharides of rabbit erythrocytes and of Forssman antigen,” Archives of Biochemistry and Biophysics, vol. 133, no. 2, pp. 464–472, 1973. View at Google Scholar
  60. U. Dabrowski, P. Hanfland, H. Egge, S. Kuhn, and J. Dabrowski, “Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Determination of branching patterns of a ceramide pentadecasaccharide by 1H nuclear magnetic resonance,” Journal of Biological Chemistry, vol. 259, no. 12, pp. 7648–7651, 1984. View at Google Scholar · View at Scopus
  61. H. Egge, M. Kordowicz, J. Peter-Katalinic, and P. Hanfland, “Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Characterization of linear, di-, and triantennary neolactoglycosphingolipids,” Journal of Biological Chemistry, vol. 260, no. 8, pp. 4927–4935, 1985. View at Google Scholar · View at Scopus
  62. P. Hanfland, M. Kordowicz, J. Peter-Katalinić, H. Egge, J. Dabrowski, and U. Dabrowski, “Structure elucidation of blood group B-like and I-active ceramide eicosa- and pentacosa-saccharides from rabbit erythrocyte membranes by combined gas chromatography-mass spectrometry; electron-impact and fast-atom-bombardment mass spectrometry; and two-dimensional correlated, relayed-coherence transfer, and nuclear overhauser effect 500-MHz 1H-N.m.r. spectroscopy,” Carbohydrate Research, vol. 178, no. 1, pp. 1–21, 1988. View at Google Scholar · View at Scopus
  63. K. Honma, H. Manabe, M. Tomita, and A. Hamada, “Isolation and partial structural characterization of macroglycolipid from rabbit erythrocyte membranes,” Journal of Biochemistry, vol. 90, no. 4, pp. 1187–1196, 1981. View at Google Scholar
  64. J. Folch, M. Lees, and G. H. Sloane Stanley, “A simple method for the isolation and purification of total lipides from animal tissues,” The Journal of Biological Chemistry, vol. 226, no. 1, pp. 497–509, 1957. View at Google Scholar · View at Scopus
  65. U. M. Abdel-Motal, K. Wigglesworth, and U. Galili, “Intratumoral injection of alpha-gal glycolipids induces a protective anti-tumor T cell response which overcomes Treg activity,” Cancer Immunology, Immunotherapy, vol. 58, no. 10, pp. 1545–1556, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Shimizu, S. Yamazaki, and S. Sakaguchi, “Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity,” Journal of Immunology, vol. 163, no. 10, pp. 5211–5218, 1999. View at Google Scholar · View at Scopus
  67. M. J. Turk, J. A. Guevara-Patiño, G. A. Rizzuto, M. E. Engelhorn, and A. N. Houghton, “Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells,” Journal of Experimental Medicine, vol. 200, no. 6, pp. 771–782, 2004. View at Publisher · View at Google Scholar · View at Scopus
  68. O. Manches, J. Plumas, L. Lui et al., “Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells,” Haematologica, vol. 90, no. 5, pp. 625–634, 2005. View at Google Scholar · View at Scopus